Stockreport

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method [Yahoo! Finance]

Pluri Inc.  (PLUR) 
PDF Technology sets stage for potential immune cell therapy advancements and targets an estimated total addressable market of $11.66 billion by 2030 HAIFA, Israel, April [Read more]